Medindia

X

Quest Diagnostics Reports Strong Performance for Fourth Quarter and Full Year 2009; Provides Guidance for 2010

Monday, January 25, 2010 Corporate News J E 4
Advertisement
- Fourth quarter diluted EPS grew 11% on revenue growth of 2.7%; cash from operations totaled $360 million

Continuing Operations

Three Months Ended

December 31, 2009

Twelve Months Ended

December 31, 2009

Consolidated

Revenue

Growth

Volume

Growth

Revenue

per Requisition

Consolidated

Revenue

Growth

Volume

Growth

Revenue

per Requisition

Reported:

2.7%

(0.3)%

2.6%

2.8%

(0.7)%

3.9%

Impact on comparisons to prior year of:

Drugs-of-abuse testing

(0.4)%

(0.8)%

0.4%

(0.7)%

(1.5)%

0.8%

Laboratory management contracts

-

-

-

(0.1)%

(0.4)%

0.3%

Number of business days

-

-

-

(0.3)%

(0.4)%

-

Foreign exchange

0.2%

-

-

(0.4)%

-

-

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Henry Schein Elects Dr. Bradley T. Sheares to Boar...
S
Landauer, Inc. Sets Date and Time for Announcement...